Form 4 AI
Back to all filings

Form 4 · Filed Jul 17, 2026, 08:15 PM UTC

CPRX/CATALYST PHARMACEUTICALS, INC.

Daly Richard J — President and CEO

AI Thesis

A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.

Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.

Transactions

11 rows
DateCodeDirectionSharesPriceValueOwned after
Jul 15, 2026Dother271,266$32$8,544,8790
Jul 15, 2026Dother33,5000
Jul 15, 2026Dother30,0000
Jul 15, 2026Dother20,0000
Jul 15, 2026Dother15,0000
Jul 15, 2026Dother1,365,3190
Jul 15, 2026Dother491,1600
Jul 15, 2026Dother381,9480
Jul 15, 2026Dother126,3160
Jul 15, 2026Dother40,0130
Jul 15, 2026Dother115,2830

Source: SEC EDGAR raw filing ↗ · Accession 0001161697-26-000173

CPRX Form 4 — Daly Richard J — Form 4 AI